利奈唑胺-话题@MedSci

#利奈唑胺#

16篇内容 | 1748人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2118084, encodeId=a3c0211808436, content=<a href='/topic/show?id=ad1e939245e' target=_blank style='color:#2F92EE;'>#达巴万星#</a>，<a href='/topic/show?id=5fa94452641' target=_blank style='color:#2F92EE;'>#奥利万星#</a>，<a href='/topic/show?id=79b51952ee8' target=_blank style='color:#2F92EE;'>#万古霉素#</a>，<a href='/topic/show?id=f09732281ed' target=_blank style='color:#2F92EE;'>#利奈唑胺#</a>，<a href='/topic/show?id=cfd353291f3' target=_blank style='color:#2F92EE;'>#感染#</a>, objectTitle=NEJM：皮肤和软组织感染的一周一次疗法, objectType=article, longId=46665, objectId=c986466655b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201502/2015020413153845.jpg, objectUrl=/article/show_article.do?id=c986466655b, replyNumber=0, likeNumber=174, createdTime=2023-03-07, rootId=0, userName=showtest, userId=8f0715, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c986466655b, moduleTitle=NEJM：皮肤和软组织感染的一周一次疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c986466655b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374087, encodeId=576b13e4087f0, content=<a href='/topic/show?id=f09732281ed' target=_blank style='color:#2F92EE;'>#利奈唑胺#</a>, objectTitle=J Antimicrob Chemother：口服康泰克唑烷治疗成人复杂皮肤和软组织感染的效果不劣于与利奈唑胺, objectType=article, longId=730960, objectId=e9b0e30960ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9b0e30960ac, replyNumber=0, likeNumber=92, createdTime=2022-07-02, rootId=0, userName=qingrejiedu, userId=2b9b368, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9b0e30960ac, moduleTitle=J Antimicrob Chemother：口服康泰克唑烷治疗成人复杂皮肤和软组织感染的效果不劣于与利奈唑胺, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9b0e30960ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374086, encodeId=7c8613e4086e1, content=<a href='/topic/show?id=f09732281ed' target=_blank style='color:#2F92EE;'>#利奈唑胺#</a>, objectTitle=Lancet Infect Dis：肺结核强化治疗期利奈唑胺优于乙胺丁醇吗？, objectType=article, longId=158954, objectId=f8b615895473, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8b615895473, replyNumber=0, likeNumber=83, createdTime=2019-01-28, rootId=0, userName=qingrejiedu, userId=2b9b368, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8b615895473, moduleTitle=Lancet Infect Dis：肺结核强化治疗期利奈唑胺优于乙胺丁醇吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8b615895473)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374085, encodeId=3b9813e4085f0, content=<a href='/topic/show?id=f09732281ed' target=_blank style='color:#2F92EE;'>#利奈唑胺#</a>, objectTitle=Clin Infect Dis：利奈唑胺治疗多药耐药结核病的更佳每日剂量？, objectType=article, longId=158049, objectId=d529158049e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d529158049e0, replyNumber=0, likeNumber=104, createdTime=2019-01-16, rootId=0, userName=qingrejiedu, userId=2b9b368, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d529158049e0, moduleTitle=Clin Infect Dis：利奈唑胺治疗多药耐药结核病的更佳每日剂量？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d529158049e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374084, encodeId=472f13e408453, content=<a href='/topic/show?id=f09732281ed' target=_blank style='color:#2F92EE;'>#利奈唑胺#</a>, objectTitle=利奈唑胺抗结核治疗专家共识, objectType=article, longId=127734, objectId=b8a312e73494, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8a312e73494, replyNumber=0, likeNumber=91, createdTime=2018-01-27, rootId=0, userName=qingrejiedu, userId=2b9b368, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8a312e73494, moduleTitle=利奈唑胺抗结核治疗专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8a312e73494)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374083, encodeId=1aef13e4083d0, content=<a href='/topic/show?id=f09732281ed' target=_blank style='color:#2F92EE;'>#利奈唑胺#</a>, objectTitle=Antimicrob Agents Chemother：利奈唑胺异常水平影响临床结局吗？, objectType=article, longId=119143, objectId=0509119143ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0509119143ca, replyNumber=0, likeNumber=84, createdTime=2017-11-09, rootId=0, userName=qingrejiedu, userId=2b9b368, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0509119143ca, moduleTitle=Antimicrob Agents Chemother：利奈唑胺异常水平影响临床结局吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0509119143ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374082, encodeId=b31f13e408296, content=<a href='/topic/show?id=f09732281ed' target=_blank style='color:#2F92EE;'>#利奈唑胺#</a>, objectTitle=Antimicrob Agents Ch：利奈唑胺异常水平影响临床结局吗？, objectType=article, longId=119142, objectId=8007119142f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8007119142f2, replyNumber=0, likeNumber=85, createdTime=2017-11-09, rootId=0, userName=qingrejiedu, userId=2b9b368, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8007119142f2, moduleTitle=Antimicrob Agents Ch：利奈唑胺异常水平影响临床结局吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8007119142f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374081, encodeId=eb5113e408159, content=<a href='/topic/show?id=f09732281ed' target=_blank style='color:#2F92EE;'>#利奈唑胺#</a>, objectTitle=Redox Biol：抗生素利奈唑胺被证明危害脂肪细胞, objectType=article, longId=102531, objectId=30e110253124, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30e110253124, replyNumber=0, likeNumber=97, createdTime=2017-06-21, rootId=0, userName=qingrejiedu, userId=2b9b368, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30e110253124, moduleTitle=Redox Biol：抗生素利奈唑胺被证明危害脂肪细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30e110253124)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374080, encodeId=620813e4080e7, content=<a href='/topic/show?id=f09732281ed' target=_blank style='color:#2F92EE;'>#利奈唑胺#</a>, objectTitle=Antimicrob Agents Ch：达托霉素与利奈唑胺用于耐万古霉素屎肠球菌血流感染的有效性？, objectType=article, longId=101360, objectId=3925101360e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3925101360e6, replyNumber=0, likeNumber=86, createdTime=2017-06-11, rootId=0, userName=qingrejiedu, userId=2b9b368, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3925101360e6, moduleTitle=Antimicrob Agents Ch：达托霉素与利奈唑胺用于耐万古霉素屎肠球菌血流感染的有效性？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3925101360e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374079, encodeId=351513e407980, content=<a href='/topic/show?id=f09732281ed' target=_blank style='color:#2F92EE;'>#利奈唑胺#</a>, objectTitle=CLIN PHARMACOKINET：对特定的败血症患者可增加利奈唑胺初始剂量使其获益, objectType=article, longId=100589, objectId=83a4100589ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83a4100589ca, replyNumber=0, likeNumber=78, createdTime=2017-06-04, rootId=0, userName=qingrejiedu, userId=2b9b368, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83a4100589ca, moduleTitle=CLIN PHARMACOKINET：对特定的败血症患者可增加利奈唑胺初始剂量使其获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83a4100589ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374078, encodeId=c5ad13e4078ec, content=<a href='/topic/show?id=f09732281ed' target=_blank style='color:#2F92EE;'>#利奈唑胺#</a>, objectTitle=Br J Clin Pharmacol：肾功能受损患者使用利奈唑胺是否调整剂量？, objectType=article, longId=92335, objectId=1f399233571, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f399233571, replyNumber=0, likeNumber=87, createdTime=2017-03-20, rootId=0, userName=qingrejiedu, userId=2b9b368, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f399233571, moduleTitle=Br J Clin Pharmacol：肾功能受损患者使用利奈唑胺是否调整剂量？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f399233571)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374077, encodeId=038e13e4077d8, content=<a href='/topic/show?id=f09732281ed' target=_blank style='color:#2F92EE;'>#利奈唑胺#</a>, objectTitle=Lancet Infect Dis：新型抗生素tedizolid疗效不劣于利奈唑胺（ESTABLISH-2试验）, objectType=article, longId=36872, objectId=2468368e289, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2468368e289, replyNumber=0, likeNumber=87, createdTime=2014-06-25, rootId=0, userName=qingrejiedu, userId=2b9b368, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2468368e289, moduleTitle=Lancet Infect Dis：新型抗生素tedizolid疗效不劣于利奈唑胺（ESTABLISH-2试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2468368e289)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374076, encodeId=31f313e4076d7, content=<a href='/topic/show?id=f09732281ed' target=_blank style='color:#2F92EE;'>#利奈唑胺#</a>, objectTitle=NEJM：药物利奈唑胺或可治疗广泛的耐药性结核病, objectType=article, longId=18126, objectId=31331812684, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31331812684, replyNumber=0, likeNumber=115, createdTime=2013-05-08, rootId=0, userName=qingrejiedu, userId=2b9b368, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31331812684, moduleTitle=NEJM：药物利奈唑胺或可治疗广泛的耐药性结核病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31331812684)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374075, encodeId=cc7713e4075d2, content=<a href='/topic/show?id=f09732281ed' target=_blank style='color:#2F92EE;'>#利奈唑胺#</a>, objectTitle=利奈唑胺对MRSA肺炎肥胖患者的疗效优于万古霉素, objectType=article, longId=9994, objectId=c6289994df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6289994df, replyNumber=0, likeNumber=96, createdTime=2012-09-30, rootId=0, userName=qingrejiedu, userId=2b9b368, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6289994df, moduleTitle=利奈唑胺对MRSA肺炎肥胖患者的疗效优于万古霉素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6289994df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374074, encodeId=be4213e40743f, content=<a href='/topic/show?id=f09732281ed' target=_blank style='color:#2F92EE;'>#利奈唑胺#</a>, objectTitle=利奈唑胺治疗是预测MRSA肺炎治疗成功的**可干预变量, objectType=article, longId=9947, objectId=918e994e94, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=918e994e94, replyNumber=0, likeNumber=84, createdTime=2012-09-28, rootId=0, userName=qingrejiedu, userId=2b9b368, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=918e994e94, moduleTitle=利奈唑胺治疗是预测MRSA肺炎治疗成功的**可干预变量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=918e994e94)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1374073, encodeId=87f913e407314, content=<a href='/topic/show?id=f09732281ed' target=_blank style='color:#2F92EE;'>#利奈唑胺#</a>, objectTitle=利奈唑胺诱发低血糖症一例, objectType=article, longId=8773, objectId=bd798e7312, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd798e7312, replyNumber=0, likeNumber=86, createdTime=2012-08-11, rootId=0, userName=qingrejiedu, userId=2b9b368, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd798e7312, moduleTitle=利奈唑胺诱发低血糖症一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd798e7312)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

利奈唑胺

2020-05-29

showtest (审核中...)

前往app查看评论内容

#达巴万星#，#奥利万星#，#万古霉素#，#利奈唑胺#，#感染#

NEJM：皮肤和软组织感染的一周一次疗法

2023-03-07发表于上海

qingrejiedu (审核中...)

前往app查看评论内容

#利奈唑胺#

J Antimicrob Chemother：口服康泰克唑烷治疗成人复杂皮肤和软组织感染的效果不劣于与利奈唑胺

2022-07-02

qingrejiedu (审核中...)

前往app查看评论内容

#利奈唑胺#

Lancet Infect Dis：肺结核强化治疗期利奈唑胺优于乙胺丁醇吗？

2019-01-28

qingrejiedu (审核中...)

前往app查看评论内容

#利奈唑胺#

Clin Infect Dis：利奈唑胺治疗多药耐药结核病的更佳每日剂量？

2019-01-16

qingrejiedu (审核中...)

前往app查看评论内容

#利奈唑胺#

利奈唑胺抗结核治疗专家共识

2018-01-27

qingrejiedu (审核中...)

前往app查看评论内容

#利奈唑胺#

Antimicrob Agents Chemother：利奈唑胺异常水平影响临床结局吗？

2017-11-09

qingrejiedu (审核中...)

前往app查看评论内容

#利奈唑胺#

Antimicrob Agents Ch：利奈唑胺异常水平影响临床结局吗？

2017-11-09

qingrejiedu (审核中...)

前往app查看评论内容

#利奈唑胺#

Redox Biol：抗生素利奈唑胺被证明危害脂肪细胞

2017-06-21

qingrejiedu (审核中...)

前往app查看评论内容

#利奈唑胺#

Antimicrob Agents Ch：达托霉素与利奈唑胺用于耐万古霉素屎肠球菌血流感染的有效性？

2017-06-11

qingrejiedu (审核中...)

前往app查看评论内容

#利奈唑胺#

CLIN PHARMACOKINET：对特定的败血症患者可增加利奈唑胺初始剂量使其获益

2017-06-04

qingrejiedu (审核中...)

前往app查看评论内容

#利奈唑胺#

Br J Clin Pharmacol：肾功能受损患者使用利奈唑胺是否调整剂量？

2017-03-20

qingrejiedu (审核中...)

前往app查看评论内容

#利奈唑胺#

Lancet Infect Dis：新型抗生素tedizolid疗效不劣于利奈唑胺（ESTABLISH-2试验）

2014-06-25

qingrejiedu (审核中...)

前往app查看评论内容

#利奈唑胺#

NEJM：药物利奈唑胺或可治疗广泛的耐药性结核病

2013-05-08

qingrejiedu (审核中...)

前往app查看评论内容

#利奈唑胺#

利奈唑胺对MRSA肺炎肥胖患者的疗效优于万古霉素

2012-09-30

qingrejiedu (审核中...)

前往app查看评论内容

#利奈唑胺#

利奈唑胺治疗是预测MRSA肺炎治疗成功的**可干预变量

2012-09-28

qingrejiedu (审核中...)

前往app查看评论内容

#利奈唑胺#

利奈唑胺诱发低血糖症一例

2012-08-11

科室
- - 订阅+
  - 更多科室
工具
服务